Skip to main content

Advertisement

SpringerLink
Log in

Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

In the industrialized world age-related macular degeneration (ARMD) is the leading cause for legal blindness beyond the age of 65 years. Recent studies indicate that the density of the macular pigment (MP) may play a central role in the development and progression of age-related maculopathy (ARM). We present results of measurements of macular pigment density (MPD) with a modified confocal scanning laser ophthalmoscope and compare macular pigment density values obtained from reflectance and autofluorescence images in healthy subjects.

Methods

A modified confocal scanning laser ophthalmoscope (Heidelberg Engineering, Heidelberg) was optimised for fundus reflectance and autofluorescence images at 488 nm and 514 nm. For autofluorescence imaging a band pass barrier filter with a short wavelength cut off at 530 nm was used. MPD maps were obtained, and MPD was evaluated within two degrees around the foveal center. In this study we included 109 healthy subjects aged from 18–75 years.

Results

Average MPD ranged between 0.16 density units (D.U.) and 0.22 D.U. depending on the techniques used for the measurement. Using the reflectance method the mean MPD was 0.16±0.06 D.U., whereas a MPD of 0.22±0.07 D.U. resulted from autofluorescence images with the 530-nm barrier filter.

Conclusions

This study demonstrates the good feasibility of MPD measurements with a modified confocal SLO. In agreement with previous studies we found higher macular pigment density values calculated from autofluorescence images than from reflectance images. We could not find any differences in MPD related to age and gender. Prospective longitudinal studies to verify the influence of MPD on the development and progression of ARM are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

References

  1. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age-related macular degeneration. Br J Ophthalmol:867–877

    Google Scholar 

  2. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–46

    CAS  PubMed  Google Scholar 

  3. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326

    CAS  PubMed  Google Scholar 

  4. Berendschot TT, Willemse-Assink JJM, Bastiaanse M, de Joung PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928–1932

    PubMed  Google Scholar 

  5. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W (1998) Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 39:2003–2011

    CAS  PubMed  Google Scholar 

  6. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CCW, Klein BEK, Klein R, Mitchell P, Sarks JP, Sarks SH, Soubrane G, Taylor HR, Vingerling JR (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39:367–374

    CAS  PubMed  Google Scholar 

  7. Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribut age study. Invest Ophthalmol Vis Sci 29:843–849

    CAS  PubMed  Google Scholar 

  8. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J (1993) Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34:2033–2040

    CAS  PubMed  Google Scholar 

  9. Bressler NM, Bressler SB (1995) Preventative ophthalmology age-related macular degeneration. Ophthalmology 102:1206–1211

    CAS  PubMed  Google Scholar 

  10. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR (1989) The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 107:847–852

    CAS  PubMed  Google Scholar 

  11. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L (1999) Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l'Age Arch Ophthalmol 117:1384–90

    Google Scholar 

  12. Delori FC (1993) Macular pigment density measured by reflectometry and fluorometry. In: Noninvasive assessment of the Visual System. OSA Technical Digest, pp 240–243

  13. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opts Socm Am 18:1212–1230

    CAS  Google Scholar 

  14. Hammond BR, Jr., Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41:1492–1497

    PubMed  Google Scholar 

  15. Holz FG, Pauleikhoff D (1996) Age-related macular degeneration. 2. Therapeutic approaches. Ophthalmologe 93:483–506

    CAS  PubMed  Google Scholar 

  16. Kirchhof B (1997) Surgical aspects of AMD, adjuvant techniques to restore visual function after macular surgery: pigment epithelial transplantation. Opthalmologica Belgica

  17. Klein R, Klein BEK, Jensen SC (1997) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy The beaver dam eye study. Ophthalmology 104:1804–1812

    CAS  PubMed  Google Scholar 

  18. Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 385:28–40

    CAS  PubMed  Google Scholar 

  19. Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age macular degeneration. Adv Pharmacol 38:537–556

    CAS  PubMed  Google Scholar 

  20. McCarty CA, Mukesh BN, Fu CL (2001) Risk factors for age-related maculopathy. Arch Ophthalmol 119:1455–1462

    CAS  PubMed  Google Scholar 

  21. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 117:1177–1187

    CAS  PubMed  Google Scholar 

  22. Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62 [Suppl 6]:1448S–1461S

    Google Scholar 

  23. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673

    CAS  PubMed  Google Scholar 

  24. Snodderly DM, Handelman GJ, Adler AJ (1991) Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci 32:268–279

    CAS  PubMed  Google Scholar 

  25. The Eye Disease Case Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110:1701–1708

    PubMed  Google Scholar 

  26. Wooten BR, Hammond BRJ, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical. Invest Ophthalmol Vis Sci 40:2481–2489

    CAS  PubMed  Google Scholar 

  27. Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240:666–671

    PubMed  Google Scholar 

  28. Young RW (1987) Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Augenheilkunde, Universität Leipzig, Liebigstrasse 10–14, 04103 , Leipzig, Germany

    Henrike Wüstemeyer, Andreas Moessner, Cornelia Jahn & Sebastian Wolf

Authors
  1. Henrike Wüstemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Moessner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cornelia Jahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sebastian Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Wolf.

Additional information

The authors have no proprietary interest in this study, which was facilitated by grant no. DFG Wo 478/11 and was presented in part at the annual meeting of the Deutsche Ophthalmologische Gesellschaft (DOG), Berlin, 2002.

Supported by DFG: Wo 478/11

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wüstemeyer, H., Moessner, A., Jahn, C. et al. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefe's Arch Clin Exp Ophthalmol 241, 647–651 (2003). https://doi.org/10.1007/s00417-003-0730-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0730-9

Keywords

Search

Navigation